434 related articles for article (PubMed ID: 7283399)
21. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
[TBL] [Abstract][Full Text] [Related]
22. Neuropathological study of the nucleus basalis of meynert in alcoholic dementia.
Akai J; Akai K
Arukoru Kenkyuto Yakubutsu Ison; 1989 Apr; 24(2):80-8. PubMed ID: 2757568
[TBL] [Abstract][Full Text] [Related]
23. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease.
Vogels OJ; Broere CA; ter Laak HJ; ten Donkelaar HJ; Nieuwenhuys R; Schulte BP
Neurobiol Aging; 1990; 11(1):3-13. PubMed ID: 2183081
[TBL] [Abstract][Full Text] [Related]
24. Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer's disease.
Allen SJ; Dawbarn D; Wilcock GK
Brain Res; 1988 Jun; 454(1-2):275-81. PubMed ID: 3409011
[TBL] [Abstract][Full Text] [Related]
25. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease.
Arendt T; Bigl V; Arendt A; Tennstedt A
Acta Neuropathol; 1983; 61(2):101-8. PubMed ID: 6637393
[TBL] [Abstract][Full Text] [Related]
26. Effects of two years of estrogen loss or replacement on nucleus basalis cholinergic neurons and cholinergic fibers to the dorsolateral prefrontal and inferior parietal cortex of monkeys.
Tinkler GP; Tobin JR; Voytko ML
J Comp Neurol; 2004 Feb; 469(4):507-21. PubMed ID: 14755532
[TBL] [Abstract][Full Text] [Related]
27. The nucleus basalis of Meynert in multi-infarct (vascular) dementia.
Mann DM; Yates PO; Marcyniuk B
Acta Neuropathol; 1986; 71(3-4):332-7. PubMed ID: 3799146
[TBL] [Abstract][Full Text] [Related]
28. Microsphere embolism-induced cortical cholinergic deafferentation and impairments in attentional performance.
Craft TK; Mahoney JH; Devries AC; Sarter M
Eur J Neurosci; 2005 Jun; 21(11):3117-32. PubMed ID: 15978021
[TBL] [Abstract][Full Text] [Related]
29. [A Copernican revolution in neuropathology. Implications of the discovery of lesions in the nucleus basalis in Alzheimer's disease].
Muñoz García D
Arch Neurobiol (Madr); 1983; 46(3):159-60. PubMed ID: 6639274
[No Abstract] [Full Text] [Related]
30. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
[TBL] [Abstract][Full Text] [Related]
31. Cholinergic neurons degenerate when exposed to conditioned medium of primary rat brain capillary endothelial cells: counteraction by NGF, MK-801 and inflammation.
Moser KV; Stöckl P; Humpel C
Exp Gerontol; 2006 Jun; 41(6):609-18. PubMed ID: 16701975
[TBL] [Abstract][Full Text] [Related]
32. Note on the pathology of the basal nucleus of Meynert in degenerative brain disorders.
Tagliavini F; Pilleri G
Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(2):277-80. PubMed ID: 6240766
[No Abstract] [Full Text] [Related]
33. Direct, complex effects of estrogens on basal forebrain cholinergic neurons.
Bora SH; Liu Z; Kecojevic A; Merchenthaler I; Koliatsos VE
Exp Neurol; 2005 Aug; 194(2):506-22. PubMed ID: 15893308
[TBL] [Abstract][Full Text] [Related]
34. Progression of age-associated cognitive impairment correlates with quantitative and qualitative loss of TrkA receptor protein in nucleus basalis and cortex.
Saragovi HU
J Neurochem; 2005 Dec; 95(5):1472-80. PubMed ID: 16219032
[TBL] [Abstract][Full Text] [Related]
35. Sundowning and circadian rhythm disorders in dementia.
Klaffke S; Staedt J
Acta Neurol Belg; 2006 Dec; 106(4):168-75. PubMed ID: 17323834
[TBL] [Abstract][Full Text] [Related]
36. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
Liberini P
Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
[No Abstract] [Full Text] [Related]
37. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
[TBL] [Abstract][Full Text] [Related]
38. Neuropathological changes in the nucleus basalis correlate with clinical measures of dementia.
Iraizoz I; Guijarro JL; Gonzalo LM; de Lacalle S
Acta Neuropathol; 1999 Aug; 98(2):186-96. PubMed ID: 10442559
[TBL] [Abstract][Full Text] [Related]
39. Neuronal counts in basal nucleus of Meynert in Alzheimer disease and in simple senile dementia.
Tagliavini F; Pilleri G
Lancet; 1983 Feb; 1(8322):469-70. PubMed ID: 6131183
[No Abstract] [Full Text] [Related]
40. Age-related loss of the AMPA receptor subunits GluR2/3 in the human nucleus basalis of Meynert.
Ikonomovic MD; Nocera R; Mizukami K; Armstrong DM
Exp Neurol; 2000 Dec; 166(2):363-75. PubMed ID: 11085901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
